Inovio Pharmaceuticals, Inc. (INO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 503.89M |
| Enterprise value | 177.14M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 292.33 |
| Price/book (mrq) | 1.42 |
| Enterprise value/revenue | 110.53 |
| Enterprise value/EBITDA | -0.55 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.88 |
| 52-week change 3 | -75.31% |
| S&P500 52-week change 3 | -6.48% |
| 52-week high 3 | 9.9600 |
| 52-week low 3 | 1.3800 |
| 50-day moving average 3 | 1.8998 |
| 200-day moving average 3 | 3.8444 |
Share statistics
| Avg vol (3-month) 3 | 7.12M |
| Avg vol (10-day) 3 | 5.79M |
| Shares outstanding 5 | 229.04M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 225.14M |
| % held by insiders 1 | 1.66% |
| % held by institutions 1 | 41.10% |
| Shares short (14 July 2022) 4 | 43.48M |
| Short ratio (14 July 2022) 4 | 6.4 |
| Short % of float (14 July 2022) 4 | 19.30% |
| Short % of shares outstanding (14 July 2022) 4 | 18.98% |
| Shares short (prior month 14 June 2022) 4 | 35.91M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:4 |
| Last split date 3 | 05 June 2014 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -19,990.89% |
Management effectiveness
| Return on assets (ttm) | -36.40% |
| Return on equity (ttm) | -70.10% |
Income statement
| Revenue (ttm) | 1.6M |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | -46.40% |
| Gross profit (ttm) | -247.47M |
| EBITDA | -316.58M |
| Net income avi to common (ttm) | -328.33M |
| Diluted EPS (ttm) | -1.5420 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 360.39M |
| Total cash per share (mrq) | 1.57 |
| Total debt (mrq) | 33.65M |
| Total debt/equity (mrq) | 9.48 |
| Current ratio (mrq) | 6.74 |
| Book value per share (mrq) | 1.57 |
Cash flow statement
| Operating cash flow (ttm) | -224.72M |
| Levered free cash flow (ttm) | -124.95M |
© 2022 Yahoo. All rights reserved.
